Olca Basturk

31PUBLICATIONS
236CO-AUTHORS
Molecular targetsSolid tumoursCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jun 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.

|May 22, 2026
Brain metastasis from KRAS wild-type pancreatic cancer and organoid correlates: a case report.

|Apr 16, 2026
Germline Pathogenic Variants in Homologous Recombination Pathway Genes Are Frequent in Pancreatobiliary Ampullary Carcinoma.

|Mar 27, 2026
POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer.

Wungki Park, Shigeaki Umeda, Marc Hilmi

|Mar 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.

Wungki Park, Catherine A O'Connor, Joanne F Chou

|Jan 27, 2026
"Horses out of the barn": pancreatic ductal adenocarcinoma frequently extends beyond the grossly visible tumour, requiring microscopic rectification for accurate T-staging.

Burcu Saka, Bahar Memis, Serdar Balci

Pageof 6

Frequent Collaborators

12 joint publications

Eileen O'Reilly

8 joint publications

Wungki Park

6 joint publications

Christine Iacobuzio-Donahue

6 joint publications

Michael F Berger